China News Service, January 7th. According to the website of the National Medical Security Administration, the National Medical Insurance Administration, the Ministry of Finance, the National Health Commission, and the National Centers for Disease Control and Prevention have recently issued "About the Implementation of "Class B and B Management" to optimize the number of patients infected with the new coronavirus. Notice on Policies Related to Medical Insurance for Treatment Expenses.

  The "Notice" requires that the inpatient medical expenses incurred by patients with new coronavirus infection in all medical institutions that meet the new coronavirus infection diagnosis and treatment plan formulated by the health department shall implement the early-stage expense protection policy, which shall be covered by basic medical insurance, serious illness insurance, and medical assistance. After the payment is made according to the regulations, the financial subsidy will be provided for the part of the personal burden, the required funds will be paid by the local finance in advance, and the central finance will subsidize 60% of the actual expenses incurred.

The policy is calculated based on the patient's admission time and will be implemented until March 31, 2023.

  Collaborate to promote the implementation of hierarchical diagnosis and treatment, guide patients to seek medical treatment at the grassroots level, and ensure the smooth and orderly medical services.

Increase medical insurance's support for grassroots medical institutions (second-level and below medical institutions) in rural areas and urban communities, and implement special protection for outpatient and emergency expenses for new coronavirus infections and suspected symptoms of insured patients in designated medical institutions of grassroots medical insurance .

Grass-roots medical institutions are encouraged to allocate enough drugs for the treatment of new coronavirus infection in the medical insurance drug catalog (including temporary additions by provinces). A minimum payment line and a cap line are set, and the reimbursement ratio is not less than 70%.

The specific regulations shall be determined by the local medical insurance department in consultation with the financial department based on research on the operation of the medical insurance fund, and will be implemented until March 31, 2023.

Outpatient and emergency expenses incurred by insured patients for the treatment of new coronavirus infection in other medical institutions shall be implemented in accordance with other medical insurance policies for Class B infectious diseases.

  The "Notice" clarifies that the temporary medical insurance payment policy for new coronavirus treatment drugs in the new coronavirus infection diagnosis and treatment plan will be implemented until March 31, 2023.

If some places consider temporarily expanding the list of medical insurance drugs due to insufficient supply of drugs, they can refer to the list of drugs for the treatment of new coronavirus infection identified by the provincial joint prevention and control mechanism, and the provincial medical insurance department will propose temporary inclusion in the local medical insurance drug list based on the operation of the medical insurance fund. The varieties, deadlines and reimbursement categories will be implemented after reporting to the National Medical Insurance Administration for record, and will be implemented until March 31, 2023.